Table 1 Thoracic radiograph observations and incidence in rhesus macaques infected with SARS-CoV-2 after one or two immunizations with unadjuvanted CoVLP, CoVLP+CpG, or CoVLP+AS03
Day 6 | Day 13 | Day 20 | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CoVLP | CoVLP+CpG | CoVLP+AS03 | Control | CoVLP | CoVLP+CpG | CoVLP+AS03 | Control | CoVLP | CoVLP+CpG | CoVLP+AS03 | Control | |||||||||||||
Lungs | R | L | R | L | R | L | R | L | R | L | R | L | R | L | R | L | R | L | R | L | R | L | R | L |
Animals challenged after one dose | ||||||||||||||||||||||||
TBLN enlargement | 0/6 | 0/6 | 1a/6 | 1a/6 | 0/6 | 0/6 | 0/4 | 0/4 | 0/3 | 0/3 | 0/3 | 0/3 | 0/3 | 0/3 | 0/2 | 0/2 | 0/3 | 0/3 | 0/3 | 0/3 | 0/3 | 0/3 | 0/2 | 0/2 |
Increase in opacity | 0/6 | 0/6 | 0/6 | 0/6 | 1/6 | 0/6 | 1/4 | 1/4 | 0/3 | 0/3 | 0/3 | 0/3 | 1/3 | 1/3 | 2/2 | 2/2 | 0/3 | 0/3 | 0/3 | 0/3 | 1/3 | 1/3 | 2/2 | 2/2 |
Loss of definition | 0/6 | 0/6 | 0/6 | 0/6 | 1/6 | 0/6 | 0/4 | 0/4 | 0/3 | 0/3 | 0/3 | 0/3 | 0/3 | 0/3 | 0/2 | 0/2 | 0/3 | 0/3 | 0/3 | 0/3 | 0/3 | 0/3 | 0/2 | 0/2 |
Animals challenged after two doses | ||||||||||||||||||||||||
TBLN enlargement | 1/6 | 1/6 | 0/6 | 1/6 | 0/6 | 0/6 | 0/4 | 1/4 | 0/3 | 0/3 | 0/3 | 0/3 | 0/4 | 0/4 | 0/2 | 0/2 | 0/3 | 0/3 | 0/3 | 0/3 | 1/4 | 1/4 | 0/2 | 0/2 |
Increase in opacity | 1/6 | 1/6 | 0/6 | 0/6 | 0/6 | 0/6 | 0/4 | 2/4 | 1/3 | 1/3 | 0/3 | 0/3 | 0/4 | 0/4 | 0/2 | 0/2 | 1/3 | 1/3 | 0/3 | 0/3 | 0/4 | 0/4 | 0/2 | 0/2 |
Loss of definition | 0/6 | 0/6 | 0/6 | 0/6 | 0/6 | 0/6 | 0/4 | 1/4 | 1/3 | 1/3 | 0/3 | 0/3 | 0/4 | 0/4 | 0/2 | 0/2 | 1/3 | 1/3 | 0/3 | 0/3 | 0/4 | 0/4 | 0/2 | 0/2 |